Attention Deficit Hyperactivity Disorder
New Data Suggests Less Abuse-Related Effects for OROS Methylphenidate
Published in Lab Business Week, June 17th, 2007
Stimulant drug abuse remains an ongoing concern for parents and physicians who prescribe medications to treat Attention Deficit Hyperactivity Disorder (ADHD). Data presented today at the 160th Annual Meeting of the American Psychiatric Association highlighted findings that long-acting OROS(R) methylphenidate had fewer reports of abuse and lower abuse-related effects compared with other long- and short-term stimulant medications for ADHD.
The unique, long-acting OROS(R) methylphenidate formulation initially releases the drug, followed by a more gradual release of the remaining dose in an ascending pattern, compared with an immediate-release, or short-acting,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-06-17)
More Articles from Lab Business Week
- Acne Vulgaris
Ranbaxy Expands Its Presence In the Us Dermatology Market - Anxiety
IMPAX Receives Final FDA Approval for Generic Xanax XR Extended Release Tablets - Cell Science
New findings from The Jackson Laboratory in the area of cell science published - Drug Development
Mylan Announces Final FDA Approval for Azithromycin Tablets - Financials
Mesa Labs (MLAB) Reports Record Quarterly and Year End Sales and Earnings - Northfield Laboratories
Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
